comprehensive
Previous article:
Novavax promises a turnaround & Lilly roils the obesity market
Next article: FDA warns J&J's Abiomed: We will regulate your software
Next article: FDA warns J&J's Abiomed: We will regulate your software
hotspot
explore
-
Readout Newsletter: Medeor's stem cell study, Moderna's stock dip
2025-08-12 09:02 -
FDA struggles to regulate food additives, sometimes for decades
2025-08-12 08:55 -
Medicare proceeds with plan to claw back hospital funds
2025-08-12 08:42 -
STAT Readout Newsletter: Today's biggest biotech updates
2025-08-12 08:12 -
Eli Lilly expects to double planned employment in Boston center
2025-08-12 07:07 -
Why health workers in Gaza are injured or die at high rates
2025-08-12 06:32